Jolt Health raises C$417,500 in private placement
What's the deal? Jolt HealthDealroom has a profile for this one. Try Dealroom → has closed a non-brokered private placement, raising C$417,500 (roughly $299,783) in gross proceeds. It accepted subscriptions for 8.35 million units at five cents per unit.
The terms: Each unit pairs one common share with one purchase warrant. Each warrant lets the holder buy an additional share at 10 cents for two years — though Jolt can accelerate the expiry if its shares trade at 25 cents or more for 10 consecutive days.
What's the endgame? Jolt Health is a life sciences company focused on health care, biotechnology, and artificial intelligence. It plans to use the net proceeds for general working capital.
The company paid C$4,574.96 in cash and issued 91,499 broker warrants to a qualified finder, exercisable at five cents for two years under the same acceleration terms. Securities issued are subject to trading restrictions until 13 December 2026.
The signal: The round sits in the smaller tier of disclosed venture financings — near the bottom by size, at roughly the 8th percentile. For a small-cap life sciences firm, that reflects the modest, incremental capital raises common on Canada's venture exchanges.
Read more: Stockwatch
Image credit: Idaho National Laboratory
